In many of the tumor samples from cancer patients, including those with colorectal carcinoma or small-cell lung carcinoma, LYAR mRNA levels were higher than in normal tissues (Supplementary Figure S1A). This evidence concerns the gene LYAR and colorectal carcinoma.